drugset / Trial / NCT02810899

Dexmedetomidine and Intelligence Development in Pediatric Patients Undergoing Craniotomy

NCT02810899 ↗

RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this randomized, double-blind and placebo-controlled pilot study is to investigate whether dexmedetomidine when used as an adjuvant to general anesthesia can decrease the harmful effects of anesthesia and surgery on intelligence development in pediatric patients undergoing craniotomy.

Timeline

Start
2015-09
Primary completion
2016-02
Completion
2016-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.5 ug/kg Intravenous

Indications